Translational Development Acquisition TDAC
NASDAQ TDAC
$10.90 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:41 PM EDT

Translational Development Acquisition Corp. (TDAC) Total Debt (2023 - 2026)

Translational Development Acquisition's (TDAC) quarterly Total Debt came in at $1.1 million in Q2 2026, up 120.0% quarter-over-quarter from $500000.0 in Q1 2026.

Analysis

Translational Development Acquisition Corp. (TDAC) Total Debt (2023 - 2026) Analysis & Trends

Translational Development Acquisition (TDAC) has reported Total Debt for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Debt changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $200000.0, changed N/A from the prior year.
  • Total Debt climbed to $1.1 million in Q2 2026 per TDAC's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $1.1 million in Q2 2026 and bottomed at $100000.0 in Q3 2025.
  • Historically, Total Debt has averaged $449500.0 across 3 years, with a median of $347500.0 in 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00